Literature DB >> 33975882

Phenotypic Heterogeneity and Metastasis of Breast Cancer Cells.

Lauren A Hapach1,2, Shawn P Carey1, Samantha C Schwager2, Paul V Taufalele2, Wenjun Wang2, Jenna A Mosier2, Nerymar Ortiz-Otero1, Tanner J McArdle3, Zachary E Goldblatt1, Marsha C Lampi1, Francois Bordeleau2,4, Jocelyn R Marshall1, Isaac M Richardson2, Jiahe Li1, Michael R King2, Cynthia A Reinhart-King5.   

Abstract

Although intratumoral genomic heterogeneity can impede cancer research and treatment, less is known about the effects of phenotypic heterogeneities. To investigate the role of cell migration heterogeneities in metastasis, we phenotypically sorted metastatic breast cancer cells into two subpopulations based on migration ability. Although migration is typically considered to be associated with metastasis, when injected orthotopically in vivo, the weakly migratory subpopulation metastasized significantly more than the highly migratory subpopulation. To investigate the mechanism behind this observation, both subpopulations were assessed at each stage of the metastatic cascade, including dissemination from the primary tumor, survival in the circulation, extravasation, and colonization. Although both subpopulations performed each step successfully, weakly migratory cells presented as circulating tumor cell (CTC) clusters in the circulation, suggesting clustering as one potential mechanism behind the increased metastasis of weakly migratory cells. RNA sequencing revealed weakly migratory subpopulations to be more epithelial and highly migratory subpopulations to be more mesenchymal. Depletion of E-cadherin expression from weakly migratory cells abrogated metastasis. Conversely, induction of E-cadherin expression in highly migratory cells increased metastasis. Clinical patient data and blood samples showed that CTC clustering and E-cadherin expression are both associated with worsened patient outcome. This study demonstrates that deconvolving phenotypic heterogeneities can reveal fundamental insights into metastatic progression. More specifically, these results indicate that migratory ability does not necessarily correlate with metastatic potential and that E-cadherin promotes metastasis in phenotypically sorted breast cancer cell subpopulations by enabling CTC clustering. SIGNIFICANCE: This study employs phenotypic cell sorting for migration to reveal a weakly migratory, highly metastatic breast cancer cell subpopulation regulated by E-cadherin, highlighting the dichotomy between cancer cell migration and metastasis. ©2021 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33975882      PMCID: PMC9067366          DOI: 10.1158/0008-5472.CAN-20-1799

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   13.312


  52 in total

1.  Metastatic colonization requires the repression of the epithelial-mesenchymal transition inducer Prrx1.

Authors:  Oscar H Ocaña; Rebeca Córcoles; Angels Fabra; Gema Moreno-Bueno; Hervé Acloque; Sonia Vega; Alejandro Barrallo-Gimeno; Amparo Cano; M Angela Nieto
Journal:  Cancer Cell       Date:  2012-11-29       Impact factor: 31.743

Review 2.  Modes of cancer cell invasion and the role of the microenvironment.

Authors:  Andrew G Clark; Danijela Matic Vignjevic
Journal:  Curr Opin Cell Biol       Date:  2015-07-14       Impact factor: 8.382

Review 3.  The Mechanics of Single Cell and Collective Migration of Tumor Cells.

Authors:  Marianne Lintz; Adam Muñoz; Cynthia A Reinhart-King
Journal:  J Biomech Eng       Date:  2017-02-01       Impact factor: 2.097

Review 4.  Involvement of partial EMT in cancer progression.

Authors:  Masao Saitoh
Journal:  J Biochem       Date:  2018-10-01       Impact factor: 3.387

Review 5.  Focal adhesion kinase: a prominent determinant in breast cancer initiation, progression and metastasis.

Authors:  Ming Luo; Jun-Lin Guan
Journal:  Cancer Lett       Date:  2009-07-29       Impact factor: 8.679

6.  Overlapping gene expression profiles of cell migration and tumor invasion in human bladder cancer identify metallothionein 1E and nicotinamide N-methyltransferase as novel regulators of cell migration.

Authors:  Y Wu; M S Siadaty; M E Berens; G M Hampton; D Theodorescu
Journal:  Oncogene       Date:  2008-08-25       Impact factor: 9.867

7.  Cell Adhesiveness Serves as a Biophysical Marker for Metastatic Potential.

Authors:  Pranjali Beri; Anna Popravko; Benjamin Yeoman; Aditya Kumar; Kevin Chen; Enio Hodzic; Alyssa Chiang; Afsheen Banisadr; Jesse K Placone; Hannah Carter; Stephanie I Fraley; Parag Katira; Adam J Engler
Journal:  Cancer Res       Date:  2019-12-19       Impact factor: 12.701

8.  Identification of the tumour transition states occurring during EMT.

Authors:  Ievgenia Pastushenko; Audrey Brisebarre; Alejandro Sifrim; Marco Fioramonti; Tatiana Revenco; Soufiane Boumahdi; Alexandra Van Keymeulen; Daniel Brown; Virginie Moers; Sophie Lemaire; Sarah De Clercq; Esmeralda Minguijón; Cédric Balsat; Youri Sokolow; Christine Dubois; Florian De Cock; Samuel Scozzaro; Federico Sopena; Angel Lanas; Nicky D'Haene; Isabelle Salmon; Jean-Christophe Marine; Thierry Voet; Panagiota A Sotiropoulou; Cédric Blanpain
Journal:  Nature       Date:  2018-04-18       Impact factor: 49.962

9.  Epithelial-type systemic breast carcinoma cells with a restricted mesenchymal transition are a major source of metastasis.

Authors:  Xiao Liu; Junjian Li; Bruno Loureiro Cadilha; Anamarija Markota; Cornelia Voigt; Zhe Huang; Peter P Lin; Daisy D Wang; Juncheng Dai; Gisela Kranz; Anna Krandick; Darko Libl; Horst Zitzelsberger; Isabella Zagorski; Herbert Braselmann; Min Pan; Sibo Zhu; Yuanchi Huang; Sebastian Niedermeyer; Christoph A Reichel; Bernd Uhl; Daria Briukhovetska; Javier Suárez; Sebastian Kobold; Olivier Gires; Hongxia Wang
Journal:  Sci Adv       Date:  2019-06-19       Impact factor: 14.136

10.  Uncovering the signaling landscape controlling breast cancer cell migration identifies novel metastasis driver genes.

Authors:  Esmee Koedoot; Michiel Fokkelman; Vasiliki-Maria Rogkoti; Marcel Smid; Iris van de Sandt; Hans de Bont; Chantal Pont; Janna E Klip; Steven Wink; Mieke A Timmermans; Erik A C Wiemer; Peter Stoilov; John A Foekens; Sylvia E Le Dévédec; John W M Martens; Bob van de Water
Journal:  Nat Commun       Date:  2019-07-05       Impact factor: 14.919

View more
  6 in total

1.  Liquid Biopsies: Flowing Biomarkers.

Authors:  Vincent Hyenne; Jacky G Goetz; Naël Osmani
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

Review 2.  Unravelling cell migration: defining movement from the cell surface.

Authors:  Francisco Merino-Casallo; Maria Jose Gomez-Benito; Silvia Hervas-Raluy; Jose Manuel Garcia-Aznar
Journal:  Cell Adh Migr       Date:  2022-12       Impact factor: 3.255

Review 3.  Mechanisms of Cell Adhesion Molecules in Endocrine-Related Cancers: A Concise Outlook.

Authors:  Yongsheng Ruan; Libai Chen; Danfeng Xie; Tingting Luo; Yiqi Xu; Tao Ye; Xiaona Chen; Xiaoqin Feng; Xuedong Wu
Journal:  Front Endocrinol (Lausanne)       Date:  2022-04-07       Impact factor: 6.055

Review 4.  Advances in the Biology, Detection Techniques, and Clinical Applications of Circulating Tumor Cells.

Authors:  Siwen Wu; Shubi Zhao; Dawei Cui; Jue Xie
Journal:  J Oncol       Date:  2022-09-02       Impact factor: 4.501

Review 5.  A narrative review of circulating tumor cells clusters: A key morphology of cancer cells in circulation promote hematogenous metastasis.

Authors:  Qiong Chen; Jueyao Zou; Yong He; Yanhong Pan; Gejun Yang; Han Zhao; Ying Huang; Yang Zhao; Aiyun Wang; Wenxing Chen; Yin Lu
Journal:  Front Oncol       Date:  2022-08-18       Impact factor: 5.738

6.  Phenotypic heterogeneity and cooperation in the metastatic cascade.

Authors:  Katherine M Young; Cynthia A Reinhart-King
Journal:  Oncoscience       Date:  2022-09-22
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.